PE20021039A1 - Composicion farmaceutica que comprende inhibidores de fosfodiesterasas y tensioactivos - Google Patents
Composicion farmaceutica que comprende inhibidores de fosfodiesterasas y tensioactivosInfo
- Publication number
- PE20021039A1 PE20021039A1 PE2002000135A PE2002000135A PE20021039A1 PE 20021039 A1 PE20021039 A1 PE 20021039A1 PE 2002000135 A PE2002000135 A PE 2002000135A PE 2002000135 A PE2002000135 A PE 2002000135A PE 20021039 A1 PE20021039 A1 PE 20021039A1
- Authority
- PE
- Peru
- Prior art keywords
- acid
- pharmaceutical composition
- cyclohexancarboxyl
- benzylamino
- pyrimidin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE DE a)0,1% A 20% DE COMPUESTOS INHIBIDORES DE FOSFODIESTERASAS TAL COMO ACIDO 4-[4-(3-CLORO-4-METOXI-BENCILAMINO)-BENZO[4,5]TIENO[2,3-d]PIRIMIDIN-2-IL]CICLOHEXANCARBOXILICO O ACIDO 4-[4-(3-CLORO-4-HIDROXI-BENCILAMINO)BENZO[4,5]TIENO[2,3-d]PIRIMIDIN-2-IL]CICLOHEXANCARBOXILICO; b)DE 5% A 60% DE UN TENSIOACTIVO CON UN VALOR DE EQUILIBRIO HIDROFILO LIPOFILO (HLB) DE ENTRE 14 Y 16,7 COMO ETOXILATOS DE ACEITE DE RICINO OPCIONALMENTE HIDROGENADO POLIETOXIETILENO; c)20% A 90% DE UN TENSIOACTIVO CON UN VALOR DE HLB DE 3 Y 5 TAL COMO UNA MEZCLA DE MONO, DI-, TRIGLICERIDOS DE ACIDOS GRASOS SATURADOS COMO ACIDO CAPRILICO O ACIDO CAPRINICO; d)HASTA 50% DE UNA MEZCLA DE SOLVENTES TAL COMO POLIETILENGLICOL CON UN PESO MOLECULAR DE 200 A 600; e)DE 0% A 15% DE UN PLASTIFICANTE COMO GLICEROL. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LA COMPOSICION PUEDE SER ESTABLE, ELEVA LA BIODISPONIBILIDAD Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE AFECCIONES CARDIOVASCULARES, INSUFICIENCIA CARDIACA, DISFUNCION ERECTIL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10107261A DE10107261B4 (de) | 2001-02-16 | 2001-02-16 | Pharmazeutische Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20021039A1 true PE20021039A1 (es) | 2002-11-14 |
Family
ID=7674278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000135A PE20021039A1 (es) | 2001-02-16 | 2002-02-15 | Composicion farmaceutica que comprende inhibidores de fosfodiesterasas y tensioactivos |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040082600A1 (es) |
| EP (1) | EP1385521A2 (es) |
| JP (1) | JP2004519489A (es) |
| KR (1) | KR20030074822A (es) |
| CN (1) | CN1649592A (es) |
| AR (1) | AR032695A1 (es) |
| BR (1) | BR0207271A (es) |
| CA (1) | CA2438401A1 (es) |
| CZ (1) | CZ20032423A3 (es) |
| DE (1) | DE10107261B4 (es) |
| EC (1) | ECSP034769A (es) |
| EE (1) | EE200300378A (es) |
| HU (1) | HUP0303141A3 (es) |
| IL (1) | IL157411A0 (es) |
| MX (1) | MXPA03007318A (es) |
| PE (1) | PE20021039A1 (es) |
| PL (1) | PL364467A1 (es) |
| RU (1) | RU2003127393A (es) |
| SK (1) | SK11352003A3 (es) |
| WO (1) | WO2002072100A2 (es) |
| ZA (1) | ZA200307216B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101065115A (zh) * | 2004-11-24 | 2007-10-31 | 默克公司 | 取代酰胺的液体和半固体口服药物制剂 |
| US8703786B2 (en) * | 2011-12-07 | 2014-04-22 | Texas Southern University | Etravirine formulations and uses thereof |
| JP6943384B2 (ja) * | 2017-03-01 | 2021-09-29 | ヱスビー食品株式会社 | 食品の食感劣化防止用ソフトカプセル、並びに、該食感劣化防止用ソフトカプセル及び食用油を含有する食品 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL102003A0 (en) * | 1991-06-03 | 1992-12-30 | Merck Sharp & Dohme | Pharmaceutical formulation of a benzodiazepine |
| DE19819023A1 (de) * | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidine |
| DE19928146A1 (de) * | 1999-06-19 | 2000-12-21 | Merck Patent Gmbh | Thienopyrimidine |
| EP1255565A1 (de) * | 2000-01-13 | 2002-11-13 | MERCK PATENT GmbH | Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler |
| DE10001021A1 (de) * | 2000-01-13 | 2001-07-19 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
-
2001
- 2001-02-16 DE DE10107261A patent/DE10107261B4/de not_active Expired - Fee Related
-
2002
- 2002-01-23 HU HU0303141A patent/HUP0303141A3/hu unknown
- 2002-01-23 JP JP2002571059A patent/JP2004519489A/ja not_active Withdrawn
- 2002-01-23 CN CNA028050061A patent/CN1649592A/zh active Pending
- 2002-01-23 CA CA002438401A patent/CA2438401A1/en not_active Abandoned
- 2002-01-23 CZ CZ20032423A patent/CZ20032423A3/cs unknown
- 2002-01-23 WO PCT/EP2002/000609 patent/WO2002072100A2/en not_active Application Discontinuation
- 2002-01-23 MX MXPA03007318A patent/MXPA03007318A/es unknown
- 2002-01-23 SK SK1135-2003A patent/SK11352003A3/sk not_active Application Discontinuation
- 2002-01-23 EE EEP200300378A patent/EE200300378A/xx unknown
- 2002-01-23 IL IL15741102A patent/IL157411A0/xx unknown
- 2002-01-23 EP EP02701263A patent/EP1385521A2/en not_active Withdrawn
- 2002-01-23 KR KR10-2003-7010607A patent/KR20030074822A/ko not_active Application Discontinuation
- 2002-01-23 BR BR0207271-8A patent/BR0207271A/pt not_active IP Right Cessation
- 2002-01-23 US US10/467,788 patent/US20040082600A1/en not_active Abandoned
- 2002-01-23 PL PL02364467A patent/PL364467A1/xx unknown
- 2002-01-23 RU RU2003127393/15A patent/RU2003127393A/ru not_active Application Discontinuation
- 2002-02-15 PE PE2002000135A patent/PE20021039A1/es not_active Application Discontinuation
- 2002-02-15 AR ARP020100516A patent/AR032695A1/es not_active Application Discontinuation
-
2003
- 2003-09-15 EC EC2003004769A patent/ECSP034769A/es unknown
- 2003-09-15 ZA ZA200307216A patent/ZA200307216B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10107261A1 (de) | 2002-09-12 |
| ZA200307216B (en) | 2005-01-13 |
| CA2438401A1 (en) | 2002-09-19 |
| RU2003127393A (ru) | 2005-01-20 |
| US20040082600A1 (en) | 2004-04-29 |
| WO2002072100A3 (en) | 2003-11-06 |
| CN1649592A (zh) | 2005-08-03 |
| PL364467A1 (en) | 2004-12-13 |
| BR0207271A (pt) | 2004-03-23 |
| WO2002072100A2 (en) | 2002-09-19 |
| IL157411A0 (en) | 2004-03-28 |
| MXPA03007318A (es) | 2003-12-04 |
| ECSP034769A (es) | 2003-12-24 |
| EP1385521A2 (en) | 2004-02-04 |
| JP2004519489A (ja) | 2004-07-02 |
| KR20030074822A (ko) | 2003-09-19 |
| CZ20032423A3 (en) | 2004-07-14 |
| AR032695A1 (es) | 2003-11-19 |
| DE10107261B4 (de) | 2005-03-10 |
| EE200300378A (et) | 2003-10-15 |
| SK11352003A3 (sk) | 2003-12-02 |
| HUP0303141A2 (hu) | 2003-12-29 |
| HUP0303141A3 (en) | 2006-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002067864A3 (en) | Coenzyme q products exhibiting high dissolution qualities | |
| UY27320A1 (es) | Nuevas composiciones farmacéuticas | |
| PT1305286E (pt) | Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento | |
| CA2567575A1 (en) | Organo-gel formulations for therapeutic applications | |
| BR9810729B1 (pt) | composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante. | |
| DE69901951D1 (de) | Verwendung gelierbarer pharmazeutischer zusammensetzungen in der parodontologie | |
| CY1105318T1 (el) | Φαρμακευτικες συνθεσεις για απο του στοματος και τοπικη χορηγηση | |
| ATE478129T1 (de) | Kerzenwachs auf triacylglycerin-basis | |
| AR028833A1 (es) | Compuestos inhibidores de metaloproteasas, composiciones farmaceuticas, uso para la manufactura de medicamentos, metodo de tratamiento y procedimiento para su preparacion | |
| RU2006120468A (ru) | Система доставки с контролируемым высвобождением для назального применения | |
| BR9810866B1 (pt) | composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos. | |
| TNSN05189A1 (en) | Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis | |
| ES2192264T3 (es) | Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2(1h)-indol-2-ona (=ziprasidona), su preparacion y su uso como antagonista de la dopamina. | |
| WO2005069933A3 (en) | Methods of treating an inflammatory-related disease | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| CL2009000241A1 (es) | Compuestos derivados de 5-(2-morfolin-4-il-7h-pirrolo[2,3-d]pirimidin-4-il)pirimidin-2-ilamina; proceso de preparacion; composicion farmaceutica; y uso de los compuestos para tratar o prevenir una enfermedad proliferativa tal como el cancer. | |
| PA8495101A1 (es) | Derivados de 13-metileritromicina | |
| DK0874640T3 (da) | Cyclosporinformulering | |
| PE20020833A1 (es) | Composiciones quimioterapicas de paclitaxel en microemulsion con mayor biodisponisibilidad oral | |
| HUP0101302A2 (hu) | Szilárd tisztálkodószer és hatásjavító forgácskompozíció | |
| PE20021039A1 (es) | Composicion farmaceutica que comprende inhibidores de fosfodiesterasas y tensioactivos | |
| WO2005041876A3 (en) | Spill resistant formulations containing clays | |
| IT1286545B1 (it) | Derivati benzo(c) chinolizinici,loro preparazione ed uso come inibitori delle 5-alfa-riduttasi | |
| WO2002059072A3 (en) | 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof | |
| ES2136198T3 (es) | Composiciones rectales que contienen odansetron en forma de su base libre. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |